Olli-Pekka Kallioniemi

Olli Kallioniemi, M.D., Ph.D. is Professor and Director of FIMM - the Institute for Molecular Medicine Finland, a newly-established Molecular Medicine Partnership Institution with the European Molecular Biology Laboratory (EMBL). He is also Director of the Academy of Finland Centre of Excellence in Translational Genome-Scale Biology. He received his M.D. in 1984 and Ph.D. in 1988 at the University of Tampere in Finland. He held several positions in the US over an 11-year period, most recently (1995-2002) as Head of Translational Genomics Section at the Cancer Genetics Branch, National Human Genome Research Institute, at NIH, Bethesda, Maryland. He is an author of 226 publications (with 20.336 citations) and editor or member of the editorial board of six journals. Invited lecturer in over 90 meetings in the past 4 years. Inventor and co-inventor of 16 issued patents, with a focus on technology development, such as Comparative Genomic Hybridization (CGH) in 1992, tissue microarrays in 1998 and cell-based RNAi microarrays in 2003.

Prof. Kallioniemi is a recipient of multiple awards, such as the EACR young investigator award in 1994, Anders Jahre Prize in 1998, NIH Director's lecture in 2000, Medal of the Swedish Medical Society in 2003, EU Marie Curie Centre of Excellence Grant in 2004, National Academy of Sciences membership (Finland) in 2005, EMBO Membership in 2006, and Harold G. Pritzker Memorial Lecture at the University of Toronto in 2006 and the AACR team science award in 2008 and the IFCC-Abbot Award for Molecular Diagnostics in 2008. After returning to Finland in 2003, Prof. Kallioniemi's group continues to be active in the area of new technology development, personalized medicine and diagnostics.